JasonBradtMD, MBA, MHA

PubMed

• 29 citations
  A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome.
  V Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz
  Blood. 2023-03-02
• 5 citations
  Comparative risk of bloodstream infection in hospitalized patients receiving intravenous medication by open, point-of-care, or closed delivery systems
  Catherine J. Mercaldi, Stephan Lanes, Jason Bradt
  American Journal of Health-System Pharmacy. 2013-06-01
• 5 citations
  Interim analysis: Open-label extension study of leniolisib for patients with APDS.
  V Koneti Rao, Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz
  The Journal of Allergy and Clinical Immunology. 2024-01-01

Journal Articles

• Leniolisib treatment for people with activated PI3K delta syndrome (APDS): a plain language summary of the phase 3 study  
  Elaine Kulm, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Niall Conlon6, Virgil A.S.H. Dalm, Julia Körholz, Vassilios Lougaris, Jo Luscombe &amp..., Future Rare Disease, 7/9/2024
• Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome  
  V. Koneti Rao, Elaine Kulm, Jennifer Grossman, David Buchbinder, Hey Chong, Jason Bradt, Sharon Webster, Anna Šedivá, Virgil A. Dalm, Gulbu Uzel, Blood Advances, 6/25/2024
• Long-Term Treatment With Selective PI3Kδ Inhibitor Leniolisib in Adults With Activated PI3Kδ Syndrome  
  V. Koneti Rao, Elaine M Kulm, Jennifer K Grossman, David K Buchbinder, Hey Chong, Jason Bradt, Sharon Webster, Anna Šedivá, Virgil A. Dalm, Gulbu Uzel, Blood Advances, 4/9/2024
• Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS  
  RESEARCH ARTICLE|ARTICLES IN PRESS Purchase Subscribe Save Share Reprints Request Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS V...., JACI, 10/3/2023
• Randomized, Placebo-Controlled, Phase 3 Trial of PI3Kδ Inhibitor Leniolisib for Activated PI3Kδ Syndrome  
  V. Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Niall Conlon, Tanya Iona Coulter, Virgil A. Dalm, Antonino ..., Blood, 11/21/2022
• Join now to see all

Abstracts/Posters

• Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients w...
  V. Koneti Rao, Sharon Webster, Anna Sediva, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Virgil A.S.H. Dalm, Antonino Trizzino, Yulia Zharankova, El..., Blood, 11/15/2022
• Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI)
  V. Koneti Rao*1, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schütz, Anna Shcherbina, Niall Conlon, Tanya Coulter, Virgil Dalm, Antonino Trizzino, Yulia..., 13th Annual Meeting of the Clinical Immunology Society, Charlotte, NC, 4/1/2022
• Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI)
  V. Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schütz, Anna Shcherbina, Niall Conlon, Tanya Coulter, Virgil Dalm, Antonino Trizzino, Yulia Z..., Selected Abstracts from the 13th Annual Meeting of the Clinical Immunology Society: 2022 Annual Meeting: Immune Deficiency and Dysregulation North American Conference, Charlotte, North Carolina, 3/31/2022
• URINARY CONTINENCE AFTER ROBOTIC PROSTATECTOMY: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND MULTI-CENTER PHASE 4 CLINICAL TRIAL EVALUATING SOLIFENACIN SUCCINATE VERSUS PLA...
  Fernando Bianco , David Albala , Laurence Belkoff , Brian Miles , James Peabody , Weizhong He , Jason Bradt , Gabriel Haas , and Thomas Ahlering, Journal of Urology, Linthicum, MD, 4/1/2014
• Dexmedetomidine Improves Outcomes For Long Term Icu Sedation When Compared To Midazolam: The Sedcom Study
  Riker R, Shehabi Y, Wisemandle W, Bokesch PM, Rocha MG, Bradt J., Chest, http://journal.publications.chestnet.org/article.aspx?articleid=1094537, 10/28/2008
• Safety and efficacy of clobazam, a novel 1, 5-benzodiazepine, in the treatment of Lennox-Gastaut syndrome
  Joan Conry, Y. Ng, S. Collins, J. Bradt, J. Stolle, K. Tracy and B. Riley, Epilepsia, 10/5/2007
• Join now to see all